Wimalarat 1994/240mg.

Methods	As for Wimalarat 1994/120mg but using 240 mg nimodipine T: 63 patients, C: 60 patients
Participants	—
Interventions	—
Outcomes	—
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Adequate sequence generation?	Low risk	Probably done
Allocation concealment?	Unclear risk	Unclear from publication
Blinding?	Low risk	Probably done
Completeness of follow‐up	High risk	30 patients withdrawn

ACEI: angiotensin‐converting enzyme inhibitor 
 ACHI: acute cerebral hemisphere infarction 
 ADL: activities of daily living 
 AF: atrial fibrillation 
 AV: atrioventricular 
 bd: twice a day 
 BP: blood pressure 
 C: control treatment 
 CCB: calcium channel blocker 
 CCF: congestive cardiac failure 
 CI: cardiac index 
 CSF: cerebrospinal fluid 
 CT: computerised tomography 
 DBP: diastolic blood pressure 
 DHCLHb: diaspirin cross‐linked haemoglobin 
 DM: diabetes mellitus 
 ECG: echocardiogram 
 EEG: electroencephalography 
 Ex: exclusions 
 FU: follow up 
 GKI: glucose‐potassium‐insulin 
 GTN: glyceryl trinitrate 
 ICH: intracerebral haemorrhage 
 IS: ischaemic stroke 
 ITT: Intention to treat 
 IU: international unit 
 iv: intravenous 
 MAP: mean arterial pressure 
 MCA: middle cerebral artery 
 MI: myocardial infarction 
 MRI: magnetic resonance imaging 
 mRS: modified Rankin Score 
 NIHSS: National Institutes of Health Stroke Scale 
 OCSP: Oxfordshire Community Stroke Project 
 PET: positron emission tomography 
 po: oral 
 PP: per protocol 
 PTX: pentoxifylline 
 PGI2: prostacyclin 
 PICH: primary intra cerebral haemorrhage 
 qid: four times per day 
 Rx: treatment 
 SAH: subarachnoid haemorrhage 
 SBP: systolic blood pressure 
 sl: sublingual 
 T: active treatment 
 tds: three times per day 
 TIA: transient ischaemic attack